Phosphine has been claimed to cause chromosomal damage at exposures close to the current time weighted average exposure standard of 0'3 ppm (0.4 mg/m3). The current study involved 31 phosphine fumigators and 21 controls during the high fumigation season. All were volunteers and were evaluated for genotoxicity variables, including micronuclei in peripheral blood lymphocytes and urine mutagenicity. In parallel, all fumigators and 17 controls were evaluated--for full haematology, multiple biochemical analysis, whole blood organochlorines, and whole blood and serum cholinesterase activity. The results for-micronuclei showed no significant differences between fumigators and controls, but detected a strong association between age and increased frequency of micronuclei. Measurement of urine mutagenicity did not show any significant difference between fumigators and controls, but did show increased excretion of mutagens in smokers. All haematological and biochemical variables were within normal ranges, except for some nonspecific changes in biochemistry. At monitored occupational exposures of < 2-4 ppm/h our results show no association between phosphine exposure and genotoxic or toxicological effects in fiunigators. (Occup Environ Med 1994;51:700-705) 
Phosphine has been an occupational health issue in Australia since the early 1950s. The establishment of codes of practice for fumigation with phosphine and improvements in the technology of storage and fumigation have resulted in lower occupational exposure to this fumigant than in previous decades in Australia' and internationally.2 Despite these achievements, exposures can be further decreased.
Effects of acute and sub-acute exposure in humans to phosphine, mainly suicidal, have been described and symptoms include headache, diarrhoea, tightness of chest, pulmonary oedema, and death.35 Phosphine is a recognised poison to mammals, birds, and most insects and its toxicity and subsequent lethality is dependent on the duration and concentration of the exposure.6 Exposure by inhalation of phosphine seems to be the most effective route of absorption as it targets the whole respiratory tract, especially the lungs. [5] [6] [7] Within the state of New South Wales, Australia, Grain Corp is the government organisation responsible for about 85% of the commercial grain stores (about 270 sites, 500 individual stores), with 31 fumigators being responsible for all phosphine fumigation. During a normal year, there are about 170-200 fumigations with phosphine that occur mainly during summer months (December-March). There are four main types of stores used by this corporation: sealed storages (gas-tight), bunker stores (temporary), SIROFLO stores (sealed base + open top), and unsealed non-SIROFLO stores.
In 1988, after the release of environmental health criteria on phosphine and selected metal phosphides,6 it became obvious that there was a lack of genotoxicity data on this compound. At the same time, phosphine was under review in the United States by the Environmental Protection Agency for renewal of the licence for its use in that country. Because of this lack of genotoxicity data, the Environmental Protection Agency demanded from the manufacturers of phosphine and metal phosphides a battery of tests for mutagenicity and carcinogenicity. These tests included an acute inhalation toxicity, an inhalation developmental toxicity, a 13 week inhalation toxicity, and Ames/Salmonella plate incorporation assay.7 In rats exposed to 10 ppm for 3 days (6 h/day), there were decreased erythrocytes, lung congestion, and increased kidney weights with coagulative necrosis of the tubular epithelium in the outer cortex. Subchronically (6 h/day, 13 weeks), there was also a dose-related decrease in body weight gain at 1 and 3 ppm, with a 5% decrease in erythrocytes, haemoglobin, and packed cell volume found in the 3 ppm group. Exposure of pregnant rats up to 4-9 ppm showed no evidence of maternal or developmental toxicity.
In 1989, Garry et al published a study that associated occupational exposure to phosphine with increases in chromosomal aberrations, which may have implications for carcinogenicity." This generated the need to evaluate the occupational health and safety of workers handling this fumigant in Australia. Our study was therefore undertaken primarily to evaluate two biomarkers of genotoxicity (induction of micronuclei in peripheral lymphocytes and urine mutagenicity), as well as several other variables (full blood count, multiple biochemical analysis, whole blood organochlorines, serum and whole blood cholinesterase) on long term fumigators who were occupationally exposed to phosphine. Environmental monitoring was also performed to provide an indication of exposure.
Materials and methods

SUBJECT SELECTION
Fumigators (n = 31) working with phosphine (mean (range) 11 6 (1-5-32) years) for the New South Wales Grain Corp and control subjects (n = 21) working on the same sites as grain handlers, mechanics, and clerks, volunteered for the study and were matched by sex, age, and smoking habit. All subjects gave signed consent for their participation in this investigation and the project was approved by the Sydney University Human Ethics Committee. Samples of blood and urine were collected over the period from February-April 1992. All subjects were given an approved personal health questionnaire by an experienced registered nurse, and details were obtained on chronic and acute illnesses, use of medication, diagnostic exposure to x rays in the past 12 months, and exposure to potential mutagens. Subjects with a history of having medication or exposure to x rays were subdivided into a separate group for evaluation of induction of micronuclei to ensure that such exposure was not a confounder.
BLOOD AND URINE COLLECTION
Blood and urine samples collected at the work sites were transported to the laboratory and processed within 12 hours. Blood was collected into six 10 ml vacuum tubes (Greiner, three tubes with sodium heparin, two tubes with EDTA and one tube without additive). The tubes with sodium heparin were used for lymphocyte culture and determination of organochlorines and cholinesterase activity. Tubes with EDTA were used for full blood counts and tubes without preservatives for multiple biochemical analysis. Urine samples (100 ml) were collected into 120 ml sterile plastic bottles and transported in a container with ice. In the laboratory, the urine samples were stored at -80'C until processing (up to four months) for urine mutagenicity.
INDUCTION OF MICRONUCLEI
Peripheral blood lymphocytes were separated from whole blood with a sterile gradient solution of Lymphoprep (sodium metrizoate, 9-6% w/v; polysaccharide, 5'6% w/v) with a mean (SD) density of 1-077 (0.001) g/ml and osmolarity of 280 (15) (Linbro, Flow Laboratories) . Two cultures for each subject were prepared, and cells were cultured at 37°C in a humidified atmosphere containing 5% CO2 for 72 hours. After 44 hours of culture, Cytochalasin-B (Cyt-B, Sigma Chemicals, USA) was added at a concentration of 5 ug/ml. After 72 hours of culture, cells were harvested and slides were prepared from 120,1 of cell suspension (2/culture) with a cytospin Shandon, England; (600 rpm, 5 min). The slides were stained with Diff-Quik Stain Set (modified Wright stain, Lab-Aids, cat 64851, Sydney, Australia), air dried for a minimum of two hours and mounted with cover slips, in Gurr XAM neutral medium (BDH Chemicals UK). A minimum of 1200 binucleated cells/subject were scored under oil immersion at 1000 x magnification. All slides were scored blind. Micronuclei were scored in binucleated cells by the criteria. (a) diameter between 1/16 to 1/3 that of the main nuclei; (b) non-refractile; (c) not linked to the main nuclei; (d) morphologically identical to but smaller than the main nuclei.
URINE MUTAGENICITY
Amberlite XAD-2 resin (BDH Chemicals, UK, 20-50 mesh) was washed with acetone once, with methanol twice, and several times with distilled water. The resin was stored at 4°C and used as required. The urine samples were centrifuged for 10 min at 800 rpm and the supernatant was passed through the chromatography column containing 2 ml of XAD-2 resin, at a rate of 2 ml/min. Adsorbed mutagens were eluted with 6 ml of acetone and collected in two 5 ml glass tubes/sample. Samples were freeze-dried and the urine residue was reconstituted in 1-5 ml of dimethyl sulphoxide. All media and solutions used in this assay were prepared as described by Maron X-C (n = 6) (n = 25) (n = 2) (n = 29) (n = 31) (n = 4) (n = 17) (n = 5) (n = 16) (n = 21) 8-2# M+ = medicated; M-= non-medicated; X+ = exposed to x rays; X-= not exposed to x rays; F = total fumigators; C = total controls.
limits of 0-1 to 40 ppm. These tubes served to overcome the limitations of the badges, which do not detect short term peak concentrations, and were used to obtain readings at a minimum of five and a maximum of 10 sampling points, based on the perceived relative risk at each point, for each fumigation. When we used badges for monitoring, the manufacturer's recommendations for calculating the average phosphine concentration in ppm were followed, where the reading in ppm x h, obtained from a printed colour comparison code on the badge, was divided by the exposure time (h): reading in ppm x h PH3 concentration in ppm = measuring period (h) Results All fumigators and controls were assessed for history of illness, use of medication and exposure to x rays in the past 12 months, as well as for diet and alcohol intake. No illnesses were recorded in fumigators or controls except for one fumigator who reported an occasional respiratory allergy. Of the 52 subjects, 10 received some form of medication, mainly antitetanus vaccine and vitamins and seven had been exposed to x rays in the past 12 months. These two events were determined to have no confounding effect on the incidences of micronuclei in the respective groups (table 1) .
The figure shows that the incidence of micronuclei in peripheral blood lymphocytes of 52 subjects divided into three comparative groups; (a) phosphine funigators (n = 31) and controls (n = 21); (b) smokers (n = 19) and non-smokers (n = 33), and (c) younger (<35 y, n = 16) and older (>,35 y, n = 36) subjects. In the first two groups, there were no significant differences in the incidence of micronuclei/1000 binucleated cells between fumigators (6-9 (4 5) and controls (7-1 (4-0) Wilcoxon, P = 0-88), and smokers (7-2 (3 9) and non-smokers (6-8 (4 2) Evaluation ofphosphine genotoxicity at occupational levels of exposure in New South Wales, Australia *Mutagenicity was assessed as follows: 0 = no significant activity in either TA100 or TA98 ±S9; + = 1 -5x background (P < 0 05; one-sided unpaired t-test); + + = 2x background (P < 0-01); + + + = 3x background (P < 0-001). The spontaneous revertant ranges for TA98 were 17-33 (-S9) and 31-50 (+ S9) and for TA100, 153-178 (-S9), and 148-169 (+ S9). The positive control, 2-aminoanthracene, consistently induced about 2500 revertants when applied at 2-5 jg/plate in the presence of S9, in all experiments.
Wilcoxon, P = 0 8). In the third group, however, there was an age related significant difference, with the younger subjects having a lower incidence of micronuclei/l000 binucleated cells (4 5 (3 4)) than the older subjects (8X1 (4 0), Wilcoxon, P < 0-001). Table 2 summarises the urine mutagenicity in Salmonella typhimurium strains TA100 and TA98 (±S9). Of a total of 27 fumigators, 15 (56%) had mutagenic activity compared with 10 (53%) out of 19 control subjects. This activity seemed to be unrelated to phosphine fumigation but there was a relation with smoking: 100% of the fumigators and 83% of the controls who smoked excreted mutagenic urine.
Haematological tests on 31 fumigators and four controls were consistent with normal values, but there was a slightly raised packed cell volume in one fumigator and one control subject. Whole blood and serum cholinesterase were within the normal range for all subjects (3-6-6-3 KU/i and 1-0-4-3 KU/l) and concentrations of organochlorines were within acceptable limits (Work Cover, New South Wales). Table 3 shows biochemical results from fumigators and controls. Overall, 54-8% of fumigators and 35 3% of controls had one or more increased liver function variables. Furthermore, 51 6% of fumigators had raised cholesterol (range 5-7-7 1 mmol/l) v 47% of controls (range 5-7-6-4 mmol/l); 45-2% of fumigators had raised triglycerides (range 2-2-4 3 mmol/l) v 52-9% of controls (range 2-2-3-8 mmol/l); 19-3% of fumigators had raised glucose (range 3 1-9-6 mmol/l) v 5 9% of controls (range 3-1-6-0 mmol/l); 12-9% of fumigators had raised urea (range 2-5-3-2 mmol/l) v 5 9% of controls (2-7 mmol/l); 53-1% of fumigators had altered concentrations of some of the liver function variables (y-glutamyl transpeptidase, serum aspartate aminotransferase, serum alanine aminotransferase, total bilirubin, alkaline phosphatase) v 35*3% of controls. All other variables were within the normal range.
The results of environmental monitoring showed phosphine exposures that varied in concentration and duration (table 4), depending on the techniques used. In the three SIROFLO fumigations monitored, no phosphine was detected in the work environment, whereas fumigation with blankets, either in sealed stores or bunkers, showed detectable concentrations varying from 0 1 to 0 8 ppm over a maximum period of one hour. In the unsealed store where fumigation was with AlP (aluminium phosphide) tablets by the "probe and sheet" method, phosphine badges (detection limits of 0-01 to 2-4 ppm) worn by three fumigators showed results of 0-8, 1 2, and 1 2 ppm/h. This technique took two hours to be performed. During 13 Urine mutagenicity has been successfully applied as a screening technique to detect occupational exposure to mutagenic substances'4 1' and dietary mutagens.'6 Our results showed no significant difference in excretion of mutagens in fumigators and controls. It is important, however, to consider that due to logistical limitations, some of the urine samples could not be collected in the 24 hour period after fumigation-neither were there pooled 24 hour specimens, as recommended by Falck et al.14 Nevertheless, when data from all subjects (fumigators and controls) were analysed for the influence of smoking habits, it was clear that cigarette smoking increased urine mutagenicity, where 100% of fumigators who smoked had mutagenic urine compared with 29% of fumigators who did not smoke. It is also important to note that none of the fumigators who did not smoke had more than double the background mutation frequency whereas 50% of the fumigators who smoked trebled their mutation frequency, compared with the spontaneous background. Of the control subjects who smoked, 83% had mutagenic urine compared with 38% of controls who did not smoke. Furthermore, 100% of the controls who smoked and had mutagenic urine had a threefold increase, whereas 80% of the controls who did not smoke but had mutagenic urine had only a 1*5-fold increase over background. This is consistent with the well documented influence of cigarette smoking on urine mutagenicity.'4 17 The results of multiple biochemical analyses showed a variety of mild changes that could be associated with phosphine exposure. Serum cholinesterase activity was within the normal range for all subjects investigated in our study. Inhibition probably higher than most of the levels currently found, due to the poorer work practices and technology that existed at that time. Nevertheless, our data show that at the current occupational levels of exposure encountered in the New South Wales stores, such an effect is not present.
Increases in serum transaminases and decreases in serum cholinesterase activity have been found in oral phosphine poisoning.3 Although such exposure would be expected to cause liver damage with a subsequent increase in serum transaminase concentrations, the effect on transaminase concentrations at a low level of chronic exposure still needs further investigation. In our study, 29% of fumigators had raised transaminases (serum aspartate aminotransferase, serum alanine aminotransferase) compared with 11-7% of controls, which may be associated and consistent with liver damage due to phosphine toxicity.6 An increase in yglutamyl transpeptidase that occurred in 34-4% of fumigators compared with 17-6% of controls, may be partly explained by alcohol consumption, where 77-4% of the fumigators and 61-9% of controls reported a medium (216-432 g/week) to high (450-648 g/week) alcohol intake. Cholesterol and triglycerides were raised in fumigators (51 6% and 45-2%, respectively) as well as in controls (47% and 52-9%, respectively). This suggests that diet (data not shown) is a significant contributor to these increases. Considering liver function in general, 53 1% of fumigators had an increase of one or more variables compared with 35.3% of controls. Although this difference was not significant (X2 = 1-68, P > 0-19), further investigations are needed to evaluate if-there are any possible biological implications. The haematological variables we evaluated were within the normal range, consistent with other findings in humans,5 but in contrast to animal studies. 7 In spite of our small sample, the results of environmental monitoring showed that the exposures experienced by the fumigators in this study are far lower than those reported previously. 28 Although phosphine is a potent poison, our results show that it is possible to keep exposure to this fumigant at levels that do not present detectable health risks as measured by the genotoxicity biomarkers used in this study. Furthermore, monitored concentrations of phosphine in the work environment showed that the SIROFLO fumigation technique resulted in the lowest occupational exposures whereas the probe and sheet method resulted in the highest. The probe and sheet method is being phased out but the SIROFLO technique is increasing in use, currently accounting for about 70% of all fumigations conducted by Grain Corp. Under current occupational exposures encountered in grain stores in New South Wales, the concentration of phosphine as measured by us ( < 2-4 ppm over a period of one hour) has not been shown to elicit any detectable adverse effects, as measured by induction of micronuclei, urine mutagenicity, and standard haematological analysis.
